Barclays’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Barclays’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-440,000	Closed	-$880K	–	8101
2014 Q1	$880K	Buy	+440,000	New	+$880K	﹤0.01%	3374

Barclays's RXII Position: Q4 2016 in Review

Barclays sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 1,700 shares — an estimated $1K sold.

Barclays first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $203K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Barclays reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Barclays sold 1,700 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $1K.
Barclays first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
Barclays's GALENA BIOPHARMA INC COM position peaked at $203K in Q4 2013.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.